Role of Oral Epithelial Cells in HIV-1 Transmission

口腔上皮细胞在 HIV-1 传播中的作用

基本信息

  • 批准号:
    6881405
  • 负责人:
  • 金额:
    $ 18.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-04-05 至 2007-03-31
  • 项目状态:
    已结题

项目摘要

The first line of defense against HIV-1 infections and the primary site for their transmission are mucosal surfaces of the oral cavity and the genital, and gastrointestinal tracts. The rate of HIV-1 transmission through oral cavity is significantly lower than the transmission through the genital or intestinal routes, although it still carries a risk. To address the question of oral resistance or susceptibility to HIV-l-infection, this application focuses on the cellular factors that reduce the transmission rate in oral cavity. Specifically, we propose to: 1. Establish whether oral epithelia are less capable of transferring HIV-1 from infected lamina propria cells into oral secretions than the genital or rectal epithelia. To accomplish this aim, approximately 50, primarily HIV-1 infected adults, not taking ART medication will be enrolled and asked to donate saliva, intestinal, cervicovaginal or seminal fluids and peripheral blood. Differences occurring between the HIV-1 released in saliva vs. the genital or rectal secretions, will be determined in the same individual with respect to: a) levels of free and cell-associated virus; b) its capacity to generate a productive infection; c) phenotype(s) (X4 or R5) of infectious viruses, and type of cells containing HIV-I. 2. Determine whether the expression of HIV-1 receptors and co-receptors and of relevant adhesion molecules on oral epithelia causes them to be less effective than the genital or rectal epithelia in transferring HIV-lfrom the apical surface to the subepithelial target cells. Differences in CD4, GaI-Cer, CCR5, CXCR4, ICAM-2 and ICAM-3 expression and the distribution of HIV-1 target cells will be ascertained on explant tissues of oral, rectal and genital origin. Moreover, their potential of epithelia to selectively transport/be infected and generate a productive infection by HIV-1 phenotypes in free or cell-associated forms will be determined. Finally, by means of epithelial cell lines, it will be established whether the free HIV-1 receptors and co-receptors released from the oral epithelial cells can prevent the access of HIV-1 to its target cells. The data generated will contribute to the understanding of mucosal HIV-1 transmission.
抵抗HIV-1感染的第一道防线和主要传播部位是口腔、生殖器和胃肠道的粘膜表面。HIV-1通过口腔传播的比率明显低于通过生殖器或肠道传播的比率,尽管它仍然存在风险。为了解决口腔对hiv - 1感染的抗性或易感性问题,本应用程序侧重于降低口腔传播率的细胞因素。具体而言,我们建议:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Zina Moldoveanu其他文献

Zina Moldoveanu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Zina Moldoveanu', 18)}}的其他基金

Induction of Immunity in Human Genital Tract: Effect of Intranasal Immunization
人类生殖道免疫诱导:鼻内免疫的效果
  • 批准号:
    7906756
  • 财政年份:
    2009
  • 资助金额:
    $ 18.13万
  • 项目类别:
Induction of Immunity in Human Genital Tract: Effect of Intranasal Immunization
人类生殖道免疫诱导:鼻内免疫的效果
  • 批准号:
    7707831
  • 财政年份:
    2009
  • 资助金额:
    $ 18.13万
  • 项目类别:
Role of Oral Epithelial Cells in HIV-1 Transmission
口腔上皮细胞在 HIV-1 传播中的作用
  • 批准号:
    6802956
  • 财政年份:
    2004
  • 资助金额:
    $ 18.13万
  • 项目类别:
NEW STRATEGIES FOR IMMUNIZATION AGAINST INFLUENZA VIRUS
流感病毒免疫的新策略
  • 批准号:
    3506174
  • 财政年份:
    1993
  • 资助金额:
    $ 18.13万
  • 项目类别:
MICROENCAPSULATED MEASLES VIRUS VACCINE
微囊麻疹病毒疫苗
  • 批准号:
    3489737
  • 财政年份:
    1993
  • 资助金额:
    $ 18.13万
  • 项目类别:
NEW STRATEGIES FOR IMMUNIZATION AGAINST INFLUENZA VIRUS
流感病毒免疫的新策略
  • 批准号:
    2066013
  • 财政年份:
    1993
  • 资助金额:
    $ 18.13万
  • 项目类别:
NEW STRATEGIES FOR IMMUNIZATION AGAINST INFLUENZA VIRUS
流感病毒免疫的新策略
  • 批准号:
    3489428
  • 财政年份:
    1991
  • 资助金额:
    $ 18.13万
  • 项目类别:

相似海外基金

A targeted combination intervention approach for acute HIV infections to curb the explosive epidemic among high-risk populations in Indonesia
针对急性艾滋病毒感染的针对性组合干预方法,遏制印度尼西亚高危人群的爆发性流行
  • 批准号:
    MR/V035304/1
  • 财政年份:
    2022
  • 资助金额:
    $ 18.13万
  • 项目类别:
    Research Grant
IMPAACT RELATED PROTOCOLS FOR THE RESEARCH ON TREATMENT, PREVENTION, DIAGNOSIS AND EPIDEMIOLOGY OF HIV INFECTIONS
HIV 感染的治疗、预防、诊断和流行病学研究的影响相关方案
  • 批准号:
    10369859
  • 财政年份:
    2021
  • 资助金额:
    $ 18.13万
  • 项目类别:
Determining the mechanisms of vascular CD8 T cell activation in CMV and HIV infections
确定 CMV 和 HIV 感染中血管 CD8 T 细胞激活的机制
  • 批准号:
    10461964
  • 财政年份:
    2021
  • 资助金额:
    $ 18.13万
  • 项目类别:
Determining the mechanisms of vascular CD8 T cell activation in CMV and HIV infections
确定 CMV 和 HIV 感染中血管 CD8 T 细胞激活的机制
  • 批准号:
    10326617
  • 财政年份:
    2021
  • 资助金额:
    $ 18.13万
  • 项目类别:
Combination HIV Prevention: Using anti-retroviral and anti-inflammatory medications to prevent new HIV infections
HIV 联合预防:使用抗逆转录病毒和抗炎药物预防新的 HIV 感染
  • 批准号:
    404211
  • 财政年份:
    2018
  • 资助金额:
    $ 18.13万
  • 项目类别:
    Operating Grants
BALTIMORE: PROJECTS TO REDUCE HIV INFECTIONS AND IMPROVE ENGAGEMENT IN HIV MEDICAL CARE AMONG MSM
巴尔的摩:减少艾滋病毒感染和提高男男性行为者参与艾滋病毒医疗护理的项目
  • 批准号:
    9078083
  • 财政年份:
    2015
  • 资助金额:
    $ 18.13万
  • 项目类别:
Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons
卫生部示范项目旨在减少男男性行为者 (MSM) 和跨性别者的艾滋病毒感染并提高他们对艾滋病毒医疗护理的参与度
  • 批准号:
    9079323
  • 财政年份:
    2015
  • 资助金额:
    $ 18.13万
  • 项目类别:
REDUCING HIV INFECTIONS AND IMPROVING ENGAGEMENT IN HIV MEDICAL CARE AMONG MSM IN MEMPHIS TN
减少田纳西州孟菲斯市 MSM 的 HIV 感染并提高其对 HIV 医疗护理的参与度
  • 批准号:
    9079336
  • 财政年份:
    2015
  • 资助金额:
    $ 18.13万
  • 项目类别:
Double-Negative T cells in SIV and HIV Infections
SIV 和 HIV 感染中的双阴性 T 细胞
  • 批准号:
    8472130
  • 财政年份:
    2012
  • 资助金额:
    $ 18.13万
  • 项目类别:
REDUCING HIV INFECTIONS AMONG COMMERCIAL SEX WORKERS IN GERT SIBANDE DISTRICT TAV
减少格特西班德区 TAV 商业性工作者的艾滋病毒感染
  • 批准号:
    8532661
  • 财政年份:
    2011
  • 资助金额:
    $ 18.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了